The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells

Oncogene

Volumn 30, Issue 6, 2011, Pages 679-689

  Booth, B W ^a,b   Boulanger, C A ^a   Anderson, L H ^a   Smith, G H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AMRL   (United States)

Author keywords

erbB2 HER2; mammary; microenvironment; regeneration; suppression of tumorigenesis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST TUMOR; CANCER GROWTH; CARCINOGENICITY; CELL DIFFERENTIATION; CELL REGENERATION; CHIMERA; CONTROLLED STUDY; DILUTION; EPITHELIUM CELL; FEMALE; INOCULATION; MALIGNANT TRANSFORMATION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MYOEPITHELIUM CELL; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SECRETORY CELL; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR CELL; TUMOR MICROENVIRONMENT; VIRUS CARCINOGENESIS; VIRUS NEUTRALIZATION;

ADIPOSE TISSUE; ANIMALS; CARCINOMA; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; EPITHELIAL CELLS; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RETROVIRIDAE INFECTIONS; TUMOR MICROENVIRONMENT; TUMOR VIRUS INFECTIONS;

MOUSE MAMMARY TUMOR VIRUS; MURINAE;

EID: 79951509549     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.439     Document Type: Article

References (32)

1. Bissell MJ, Inman J. (2008). Reprogramming stem cells is a micro-environmental task. Proc Natl Acad Sci USA 105: 15637-15638.
2. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R et al. (2000). Induction of mammary gland development in estrogen rece (Pubitemid 32250463)
3. Booth BW, Mack DL, Androutsellis-Theotokis A, McKay RD, Boulanger CA, Smith GH. (2008). The mammary microenviron-ment alters the differentiation repertoire of neural stem cells. Proc Natl Acad Sci USA 105: 14891-14896.
4. Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P. (1989). Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57: 931-936. (Pubitemid 19168373)
5. Boulanger CA, Mack DL, Booth BW, Smith GH. (2007). Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc Natl Acad Sci USA 104: 3871-3876. (Pubitemid 47181546)
6. Boulanger CA, Wagner KU, Smith GH. (2005). Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene 24: 552-560. (Pubitemid 40188560)
7. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. (1998). A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 95: 5076-5081. (Pubitemid 28208553)
8. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19: 968-988. (Pubitemid 30153780)
9. Choong LY, Lim S, Loh MC, Man X, Chen Y, Toy W et al. (2007). Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics. Mol Cancer Ther 6: 2828-2842. (Pubitemid 350206763)
10. DeOme KB, Faulkin Jr LJ, Bern HA, Blair PB. (1959). Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19: 515-520.
11. Dolberg DS, Bissell MJ. (1984). Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature 309: 552-556. (Pubitemid 14109376)
12. Gerschenson M, Graves K, Carson SD, Wells RS, Pierce GB. (1986).Regulation of melanoma by the embryonic skin. Proc Natl Acad Sci USA 83: 7307-7310. (Pubitemid 16000510)
13. Guy CT, Cardiff RD, Muller WJ. (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961.
14. Guy CT, Cardiff RD, Muller WJ. (1996). Activated neu induces rapid tumor progression. J Biol Chem 271: 7673-7678. (Pubitemid 26107049)
15. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578-10582.
16. Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU. (2004). Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 23: 6980-6985. (Pubitemid 39279998)
17. Illmensee K, Mintz B. (1976). Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci USA 73: 549-553.
18. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2007). Cancer statistics, 2007. CA Cancer J Clin 57: 43-66. (Pubitemid 46148091)
19. Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C et al. (2010). Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell 65-76.
20. Kordon EC, Smith GH. (1998). An entire functional mammary gland may comprise the progeny from a single cell. Development 125: 1921-1930. (Pubitemid 28274378)
21. Mallepell S, Krust A, Chambon P, Brisken C. (2006). Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 103: 2196-2201. (Pubitemid 43271646)
22. McCullough KD, Coleman WB, Ricketts SL, Wilson JW, Smith GJ, Grisham JW. (1998). Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc Natl Acad Sci USA 95: 15333-15338. (Pubitemid 29018699)
23. Mintz B, Illmensee K. (1975). Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 72: 3585-3589.
24. Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD et al. (2002). Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell 2: 451-461. (Pubitemid 41043950)
25. Mueller SO, Clark JA, Myers PH, Korach KS. (2002). Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology 143: 2357-2365. (Pubitemid 34521582)
26. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105-115.
27. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. (1999). Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 18: 2149-2164. (Pubitemid 29179172)
28. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182. (Pubitemid 17231334)
29. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712. (Pubitemid 19147683)
30. Smith GH, Medina D. (2008). Re-evaluation of mammary stem cell biology based on in vivo transplantation. Breast Cancer Res 10: 203.
31. Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH. (2002). An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 129: 1377-1386. (Pubitemid 34874159)
32. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L et al. (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 25: 4323-4330. (Pubitemid 27485212)